SEA VII Management, LLC - May 10, 2022 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Signature
SEA VII MANAGEMENT, LLC, By: /s/ Carolina A. Picazo, Chief Administrative Officer & Chief Compliance Officer
Stock symbol
DH
Transactions as of
May 10, 2022
Transactions value $
-$99,166
Form type
4
Date filed
5/12/2022, 05:17 PM
Previous filing
Nov 24, 2021
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DH Class B Common Stock Other -2.72M -10.13% 24.1M May 10, 2022 See note F1, F2, F3
transaction DH Class A Common Stock Conversion of derivative security +2.72M +97.32% 5.51M May 10, 2022 See note F1, F2, F3
transaction DH Class A Common Stock Other $0 -2.99M -54.34% $0.00 2.52M May 10, 2022 See note F3, F4
transaction DH Class A Common Stock Sale -$23.2K -1.49K -0.06% $15.55 2.51M May 11, 2022 See note F3, F5
transaction DH Class A Common Stock Sale -$39.7K -2.55K -0.1% $15.55 2.51M May 11, 2022 See note F3, F6
transaction DH Class A Common Stock Sale -$13.4K -811 -0.03% $16.52 2.51M May 11, 2022 See note F3, F7
transaction DH Class A Common Stock Sale -$22.9K -1.39K -0.06% $16.52 2.51M May 11, 2022 See note F3, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DH LLC Units of AIDH Topco, LLC Conversion of derivative security -2.72M -10.13% 24.1M May 10, 2022 Class A Common Stock 2.72M See note F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1 for the text of footnote (1).
F2 See Exhibit 99.1 for the text of footnote (2).
F3 See Exhibit 99.1 for the text of footnote (3).
F4 See Exhibit 99.1 for the text of footnote (4).
F5 See Exhibit 99.1 for the text of footnote (5).
F6 See Exhibit 99.1 for the text of footnote (6).
F7 See Exhibit 99.1 for the text of footnote (7).
F8 See Exhibit 99.1 for the text of footnote (8).

Remarks:

Christopher T. Mitchell, a Managing Director of Spectrum and Jeffrey C. Haywood, a Managing Director of Spectrum (together, the "Spectrum Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Spectrum Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Spectrum Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes.